Form 4 Tracker
Adaptive Biotechnologies Corp
ADPT

58 insider filings · Latest: Aug 10, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 21, 2026Apr 21 10:07 PMJulie RubinsteinPresident and COO
Sale
30,941$14.66$453.6K395,146(D)

View →

Apr 20, 2026Apr 21 10:07 PMJulie RubinsteinPresident and COO
Sale
19,060$14.55$277.3K399,484(D)

View →

Apr 17, 2026Apr 21 10:07 PMJulie RubinsteinPresident and COO
Sale
19,060$14.57$277.7K403,822(D)

View →

Apr 16, 2026Apr 16 11:36 PMJulie RubinsteinPresident and COO
Sale
19,060$14.18$270.3K408,160(D)

View →

Apr 15, 2026Apr 16 11:36 PMJulie RubinsteinPresident and COO
Sale
19,060$14.61$278.5K412,498(D)

View →

Apr 14, 2026Apr 16 11:36 PMJulie RubinsteinPresident and COO
Sale
19,060$14.56$277.5K416,836(D)

View →

Apr 13, 2026Apr 13 11:44 PMJulie RubinsteinPresident and COO
Sale
19,060$13.15$250.6K421,174(D)

View →

Apr 10, 2026Apr 13 11:44 PMJulie RubinsteinPresident and COO
Sale
19,060$12.77$243.3K425,512(D)

View →

Apr 9, 2026Apr 13 11:44 PMJulie RubinsteinPresident and COO
Sale
19,060$13.86$264.2K429,850(D)

View →

Apr 8, 2026Apr 10 10:52 PMFrancis LOChief People Officer
Sale
22,564$15.07$340.0K271,154(D)

View →

Apr 8, 2026Apr 10 10:48 PMHarlan S RobinsChief Scientific Officer
Sale
10,000$14.85$148.5K1,512,058(D)

View →

Apr 8, 2026Apr 8 11:51 PMChad M RobinsDirector, CEO and Chairman
Sale
37,263$15.19$566.0K2,180,518(D)

View →

Apr 6, 2026Apr 8 11:51 PMChad M RobinsDirector, CEO and Chairman
Sale
83,332$14.41$1.2M2,217,781(D)

View →

Apr 8, 2026Apr 8 11:48 PMJulie RubinsteinPresident and COO
Sale
30,941$14.83$458.9K434,188(D)

View →

Apr 7, 2026Apr 8 11:48 PMJulie RubinsteinPresident and COO
Sale
19,060$13.56$258.5K438,526(D)

View →

Apr 6, 2026Apr 8 11:48 PMJulie RubinsteinPresident and COO
Sale
19,060$14.33$273.1K442,864(D)

View →

Apr 8, 2026Apr 8 8:58 PMHarlan Robins
Proposed Sale
10,000$14.84$148.4K

View →

Apr 8, 2026Apr 8 8:58 PMChad Robins
Proposed Sale
37,263$14.84$553.0K

View →

Apr 8, 2026Apr 8 8:33 PMFRANCIS LO
Proposed Sale
22,564$13.71$309.4K

View →

Apr 6, 2026Apr 6 9:22 PMChad Robins
Proposed Sale
83,332$14.08$1.2M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 12, 2026Mar 14 1:36 AMJulie RubinsteinPresident and COO
Option Exercise
14,722$6.5577,549(D)

View →

Mar 11, 2026Mar 14 1:36 AMJulie RubinsteinPresident and COO
Option Exercise
14,722$6.5592,271(D)

View →

Mar 10, 2026Mar 11 12:04 AMJulie RubinsteinPresident and COO
Option Exercise
15,122$12.14403,539(D)

View →

Mar 9, 2026Mar 11 12:04 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14403,939(D)

View →

Mar 6, 2026Mar 11 12:04 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14415,820(D)

View →

Mar 3, 2026Mar 6 1:05 AMMichelle Renee GriffinDirector
Option Exercise
48,044$3.990(D)

View →

Mar 5, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14427,701(D)

View →

Mar 4, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14439,582(D)

View →

Mar 3, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14451,463(D)

View →

Feb 4, 2026Feb 7 12:30 AMKyle PiskelChief Financial Officer
Option Exercise
2,145$12.142,146(D)

View →

← Previous

Page 3 of 3